Noguchi C T, Rodgers G P, Schechter A N
Prog Clin Biol Res. 1987;240:381-91.
We have demonstrated that the extent of intracellular polymerization of deoxyhemoglobin S can be predicted from knowledge of intracellular hemoglobin concentration, composition and oxygen saturation. Furthermore, we have demonstrated that polymer, which appears to be the main determinant of abnormal red cell rheology, can be detected in sickle erythrocytes at high oxygen saturation values and is not significantly affected by membrane and other cellular constituents. Some of the factors which modify the pathophysiology of sickle cell anemia can be classified as genetic or cellular. To analyze in more detail the genetic factors, we examined 12 sickle syndromes. When the effects of these genotype differences are analyzed for their changes in hemoglobin composition and concentration, we found that polymer formation can account for 80% of the variation in hemolytic and clinical severity. Cell heterogeneity can also modify polymer formation. The premature increases in erythrocyte density (intracellular hemoglobin concentration) in sickle cell anemia increases polymerization tendency. Homozygous alpha-thalassemia in sickle cell patients reduces this increase in cell heterogeneity and improves the hemolytic aspect of the sickle cell disease. For homozygous sickle cell patients we find that the broader density distributions (higher degree of cell heterogeneity) are associated with those cell populations with greater tendency of polymer formation. However, the major utility of our knowledge of intracellular polymerization appears to be its value in defining quantitatively the goals of the major therapeutic approaches with respect to how much inhibition of polymerization would be necessary to achieve various levels of amelioration of disease processes. The primary determinant of the amount of polymer formation within the SS erythrocyte is the extent of oxygen saturation. We measured intracellular polymer formation in SS erythrocytes using carbon-13/proton double nuclear magnetic resonance. As the oxygen saturation is decreased below about 90% oxygen saturation, we begin to see the appearance of polymer which steadily increases with decreasing oxygen saturation. The total intracellular hemoglobin concentration also affects the amount of polymer formed. By examining polymer formation in fractionated subpopulations of SS erythrocytes at various density values (or intracellular hemoglobin concentrations) we demonstrated that the polymer fraction increased with increasing intracellular hemoglobin concentration for any given oxygen saturation.(ABSTRACT TRUNCATED AT 400 WORDS)
我们已经证明,脱氧血红蛋白S的细胞内聚合程度可以根据细胞内血红蛋白浓度、组成和氧饱和度来预测。此外,我们还证明,聚合物似乎是异常红细胞流变学的主要决定因素,在高氧饱和度值下可在镰状红细胞中检测到,并且不受膜和其他细胞成分的显著影响。一些改变镰状细胞贫血病理生理学的因素可分为遗传因素或细胞因素。为了更详细地分析遗传因素,我们研究了12种镰状综合征。当分析这些基因型差异对血红蛋白组成和浓度变化的影响时,我们发现聚合物形成可解释80%的溶血和临床严重程度变化。细胞异质性也会改变聚合物形成。镰状细胞贫血中红细胞密度(细胞内血红蛋白浓度)的过早增加会增加聚合倾向。镰状细胞患者的纯合α地中海贫血可减少这种细胞异质性增加,并改善镰状细胞病的溶血方面。对于纯合镰状细胞患者,我们发现更宽的密度分布(更高程度的细胞异质性)与那些具有更大聚合物形成倾向的细胞群体相关。然而,我们对细胞内聚合的了解的主要用途似乎在于其在定量定义主要治疗方法目标方面的价值,即就实现疾病过程的各种改善水平而言,需要多少聚合抑制。SS红细胞内聚合物形成量的主要决定因素是氧饱和度。我们使用碳-13/质子双核磁共振测量SS红细胞内的聚合物形成。当氧饱和度降至约90%以下时,我们开始看到聚合物的出现,其随着氧饱和度的降低而稳步增加。细胞内总血红蛋白浓度也会影响形成的聚合物量。通过检查不同密度值(或细胞内血红蛋白浓度)的SS红细胞分级亚群中的聚合物形成,我们证明,对于任何给定的氧饱和度,聚合物分数随细胞内血红蛋白浓度的增加而增加。(摘要截短于400字)